kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.83%78.16B | -12.10%55.25B | -1.10%285.68B | -8.38%80.48B | -2.30%70.52B | 6.60%71.82B | 2.27%62.86B | 11.93%288.87B | 14.40%87.85B | 3.58%72.18B |
Cost of revenue | 7.16%70.28B | -11.97%51.42B | -2.77%259.6B | -12.23%70.12B | -1.41%65.59B | 4.81%65.48B | 0.54%58.41B | 7.50%266.99B | 8.70%79.89B | 4.48%66.52B |
Gross profit | 59.61%7.87B | -13.83%3.83B | 19.21%26.08B | 30.15%10.36B | -12.77%4.93B | 29.56%6.35B | 32.01%4.45B | 125.19%21.88B | 141.74%7.96B | -5.97%5.65B |
Operating expense | 7.52%4.69B | 13.50%4.79B | 6.89%17.93B | 5.50%4.82B | 6.26%4.36B | 7.52%4.53B | 8.52%4.22B | 6.19%16.77B | 4.08%4.57B | 6.76%4.1B |
Operating profit | 457.44%3.18B | -514.78%-954M | 59.65%8.16B | 63.33%5.54B | -63.16%571M | 165.59%1.81B | 144.49%230M | 184.04%5.11B | 409.77%3.39B | -28.54%1.55B |
Net non-operating interest income (expenses) | -34.29%-94M | -93.75%-62M | -74.19%-216M | -140.00%-72M | -94.44%-70M | -31.25%-42M | -23.08%-32M | 15.07%-124M | 28.57%-30M | 5.26%-36M |
Non-operating interest income | 50.00%6M | 25.00%5M | 25.00%20M | 50.00%6M | -20.00%4M | 50.00%6M | 33.33%4M | -27.27%16M | -20.00%4M | 0.00%5M |
Non-operating interest expense | 35.14%100M | 86.11%67M | 68.57%236M | 129.41%78M | 80.49%74M | 33.33%48M | 24.14%36M | -16.67%140M | -27.66%34M | -4.65%41M |
Net investment income | 266.34%677M | -31.56%488M | 897.00%997M | 579.84%843M | 12.10%-407M | -210.20%-152M | 46.11%713M | -76.64%100M | -53.73%124M | -241.16%-463M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 1,805.26%362M | 261M | -89.37%291M | -83.83%27M | -99.18%19M | 3,211.36%2.74B | 427.45%167M | 2.32B | ||
Income from associates and other participating interests | 52.08%549M | 282.35%195M | 352.50%1.09B | 1,342.86%348M | 47.95%361M | 283.53%326M | 183.61%51M | -70.98%240M | -106.09%-28M | 41.86%244M |
Special income (charges) | 0 | -346.15%-232M | -3,320.00%-171M | 0 | -114.57%-52M | -145.45%-5M | 0 | |||
Less:Other special charges | ---- | ---- | 3,140.00%162M | ---- | ---- | ---- | ---- | 101.32%5M | ---- | ---- |
Less:Write off | --0 | ---- | 48.94%70M | --9M | --0 | ---- | ---- | 123.81%47M | --0 | --0 |
Other non-operating income (expenses) | -157.95%-102M | -42.86%-50M | 58.19%-125M | -256.06%-235M | 291.11%176M | 85.02%-31M | 50.70%-35M | -82.32%-299M | 64.32%-66M | 336.84%45M |
Income before tax | 603.85%4.58B | -113.04%-121M | 29.14%9.96B | 76.73%6.28B | -82.22%650M | 205.09%2.1B | 598.92%928M | 258.53%7.71B | 659.69%3.55B | 21.39%3.66B |
Income tax | 1,098.54%1.64B | -125.36%-35M | 11.67%2.54B | 252.39%1.92B | -86.58%137M | -40.38%344M | 6.98%138M | -10.48%2.27B | -59.73%544M | 31.07%1.02B |
Net income | 471.73%2.93B | -110.90%-86M | 36.44%7.42B | 45.03%4.36B | -80.52%513M | 1,453.10%1.76B | 349.68%789M | 173.48%5.44B | 251.51%3.01B | 18.02%2.63B |
Net income continuous operations | 471.73%2.93B | -110.89%-86M | 36.43%7.42B | 44.98%4.36B | -80.52%513M | 1,481.08%1.76B | 350.79%790M | 173.50%5.44B | 251.56%3.01B | 18.01%2.63B |
Noncontrolling interests | 144.00%61M | -57.89%8M | -20.10%155M | 33.33%96M | -39.02%25M | -74.14%15M | -17.39%19M | 246.43%194M | 260.00%72M | 173.33%41M |
Net income attributable to the company | 489.94%2.87B | -112.22%-94M | 38.53%7.27B | 45.30%4.27B | -81.20%487M | 3,008.93%1.74B | 326.18%769M | 170.32%5.25B | 246.39%2.94B | 16.92%2.59B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 489.94%2.87B | -112.22%-94M | 38.53%7.27B | 45.30%4.27B | -81.20%487M | 3,008.93%1.74B | 326.18%769M | 170.32%5.25B | 246.39%2.94B | 16.92%2.59B |
Gross dividend payment | ||||||||||
Basic earnings per share | 488.53%27.19 | -112.30%-0.9 | 38.01%68.99 | 44.77%40.52 | -81.31%4.62 | 3,018.87%16.53 | 325.23%7.32 | 170.15%49.99 | 246.01%27.99 | 16.71%24.72 |
Diluted earnings per share | 487.59%27.1318 | -112.30%-0.9 | 38.01%68.99 | 44.77%40.4578 | -81.32%4.6175 | 3,017.66%16.5236 | 325.23%7.32 | 170.15%49.99 | 245.78%27.9459 | 16.74%24.72 |
Dividend per share | 0 | 0 | 2.78%37 | 5.56%19 | 0 | 0.00%18 | 0 | 44.00%36 | 260.00%18 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |